Hydromorphone Drug Profile

What is Hydromorphone?

Hydromorphone is a powerful opioid analgesic medication derived from morphine and belonging to the phenanthrene class of opioids. It is prescribed for the management of severe pain when other pain medications are inadequate or not tolerated. Hydromorphone is approximately 5-7 times more potent than morphine and is available in both immediate-release and extended-release formulations.

Uses

Hydromorphone is prescribed for several pain management situations:

• Severe acute pain: Management of intense short-term pain following major surgery, trauma, or medical procedures
• Cancer pain: Treatment of moderate to severe pain in cancer patients, particularly when other opioids are ineffective
• Chronic pain: Long-term management of severe pain conditions when extended-release formulations are appropriate
• Post-operative pain: Relief of significant pain following surgical procedures when non-opioid medications are insufficient
• End-of-life care: Palliative pain management in hospice and terminal care settings

How it works

Hydromorphone works by binding to mu-opioid receptors in the brain and spinal cord, which are part of the body’s natural pain control system. When these receptors are activated, they block pain signals from reaching the brain and trigger the release of neurotransmitters that reduce pain perception. This mechanism also affects areas of the brain responsible for breathing and consciousness, which explains both the pain-relieving effects and the potential for respiratory depression.

Side effects

Common side effects include:

Submit Your Paper

• Drowsiness and sedation
• Nausea and vomiting
• Constipation
• Dizziness and lightheadedness
• Dry mouth
• Sweating
• Headache
• Confusion or mental clouding

Serious side effects requiring immediate medical attention:

• Respiratory depression (slow or difficult breathing)
• Severe allergic reactions including swelling of face, lips, or throat
• Signs of overdose including extreme drowsiness, cold/clammy skin, or loss of consciousness
• Severe hypotension (dangerously low blood pressure)
• Adrenal insufficiency with prolonged use

Warnings and precautions

• High addiction potential: Hydromorphone carries significant risk for physical dependence, tolerance, and addiction, even when used as prescribed
• Respiratory conditions: Should be avoided or used with extreme caution in patients with respiratory depression, severe asthma, or other breathing problems
• Pregnancy and breastfeeding: Can cause withdrawal symptoms in newborns and passes into breast milk; use only when benefits clearly outweigh risks
• Liver and kidney impairment: Dosage adjustments may be necessary in patients with hepatic or renal dysfunction as the drug is metabolized by the liver and excreted by the kidneys
• Elderly patients: Increased sensitivity to opioid effects requires careful dosing and monitoring in older adults

Interactions

• Central nervous system depressants: Alcohol, benzodiazepines, and barbiturates can cause dangerous respiratory depression and sedation
• MAO inhibitors: Can cause severe and potentially fatal reactions including serotonin syndrome
• Muscle relaxants: Increased risk of respiratory depression and sedation when combined with medications like cyclobenzaprine
• Antihistamines: Sedating antihistamines can enhance drowsiness and respiratory depression
• CYP3A4 inhibitors: Medications like ketoconazole and erythromycin may increase hydromorphone levels
• Anticholinergic medications: May increase risk of severe constipation and urinary retention
• Diuretics: Opioids may reduce the effectiveness of diuretic medications
• Rifampin: May decrease hydromorphone effectiveness by increasing its metabolism

Check interactions with the GMJ Interaction Checker

Dosage

Hydromorphone dosing varies significantly based on the patient’s pain severity, opioid tolerance, and individual response. For opioid-naive adults, immediate-release formulations typically start at 2-4 mg every 4-6 hours as needed for pain. Extended-release formulations are reserved for patients already tolerant to opioids and requiring around-the-clock pain management. Intravenous doses are much lower, typically 0.2-1 mg every 2-3 hours as needed. Dosage must always be individualized and determined by a healthcare provider, with careful titration to achieve adequate pain control while minimizing side effects. Patients should never adjust their dose without medical supervision due to the high risk of overdose.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).